Please login or register first to view this content.
![]() |
Why LUGPA Embraces Managing Advanced Genitourinary Cancers Neal Shore, MD, FACS |
|
---|---|---|
Medical Director, Certified Physician Investigator |
![]() |
Bladder Cancer Biomarkers: New and Old Michael Cookson, MD |
|
---|---|---|
Professor & Chairman, Department of Urology |
![]() |
AUA Guidelines: Non-muscle Invasive Bladder Cancer Sam Chang, MD |
|
---|---|---|
Professor of Urologic Surgery and Oncology |
![]() |
Intravesical Therapy: When Bacillus Calmette-Guerin Fails Noah Hahn, MD |
|
---|---|---|
Associate Professor of Oncology and Urology |
![]() |
Trinity Bivalacqua, MD, PhD | |
---|---|---|
Director of Urology Oncology |
![]() |
Immunotherapy for Advanced Bladder Cancer: The Next Frontier Arjun Balar, MD |
|
---|---|---|
Assistant Professor, Department of Medicine |
![]() |
Targeted Therapies for Renal Cell Carcinoma Won Kim, MD |
|
---|---|---|
Assistant Professor of Medicine and Urology |
![]() |
Immunotherapy of Renal Cell Carcinoma Hans Hammers, MD, PhD |
|
---|---|---|
Associate Professor, Internal Medicine |
![]() |
Genitourinary Oncology: A Peek Over the Horizon Dan Theodorescu, MD, PhD |
|
---|---|---|
Paul A. Bunn, Jr. Endowed Chair in Cancer Research |